[go: up one dir, main page]

MA31982B1 - Procede de preparation de composes morphiniques - Google Patents

Procede de preparation de composes morphiniques

Info

Publication number
MA31982B1
MA31982B1 MA32893A MA32893A MA31982B1 MA 31982 B1 MA31982 B1 MA 31982B1 MA 32893 A MA32893 A MA 32893A MA 32893 A MA32893 A MA 32893A MA 31982 B1 MA31982 B1 MA 31982B1
Authority
MA
Morocco
Prior art keywords
compound
morphine
compounds
unsaturated
relates
Prior art date
Application number
MA32893A
Other languages
Arabic (ar)
English (en)
Inventor
Alain Dlubala
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39099817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31982(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MA31982B1 publication Critical patent/MA31982B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/02—Purification; Separation; Stabilisation; Use of additives by treatment giving rise to a chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un procédé de préparation de composés morphiniques à faible teneur en composés ±-² insaturés, comportant les étapes de : (i) mise en contact du composé morphinique brut avec une base, à ph supérieur à 13 et dans des conditions permettant la réaction d'addition de michael sur le(s) composé(s) ±-² insaturés présents; (ii) séparation du composé morphinique du mélange réactionnel; et (iii) le cas échéant, séparation du produit d'addition formé du composé morphinique. Elle vise également une composition comprenant au moins 99 % en poids sec de composé morphinique ou d'un de ses sels pharmaceutiquement acceptables et un composé ±-²-insaturé en une teneur inférieure à 100 ppm.
MA32893A 2007-11-09 2010-06-07 Procede de preparation de composes morphiniques MA31982B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0758923A FR2923484B1 (fr) 2007-11-09 2007-11-09 Procede de preparation de composes morphiniques
US2194908P 2008-01-18 2008-01-18
PCT/FR2008/001558 WO2009092912A1 (fr) 2007-11-09 2008-11-06 Procede de preparation de composes morphiniques

Publications (1)

Publication Number Publication Date
MA31982B1 true MA31982B1 (fr) 2011-01-03

Family

ID=39099817

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32893A MA31982B1 (fr) 2007-11-09 2010-06-07 Procede de preparation de composes morphiniques

Country Status (21)

Country Link
US (1) US8455509B2 (fr)
EP (1) EP2231673A1 (fr)
JP (1) JP2011503040A (fr)
KR (1) KR20100083815A (fr)
CN (1) CN101868462A (fr)
AR (1) AR069225A1 (fr)
AU (1) AU2008348675A1 (fr)
BR (1) BRPI0820300A2 (fr)
CA (1) CA2705251A1 (fr)
CL (1) CL2008003333A1 (fr)
EA (1) EA017287B1 (fr)
FR (1) FR2923484B1 (fr)
IL (1) IL205601A0 (fr)
MA (1) MA31982B1 (fr)
MX (1) MX2010005124A (fr)
NZ (1) NZ585218A (fr)
SG (1) SG186591A1 (fr)
TW (1) TW200936592A (fr)
UY (1) UY31460A1 (fr)
WO (1) WO2009092912A1 (fr)
ZA (1) ZA201003241B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN102174049A (zh) * 2011-03-11 2011-09-07 山东新华制药股份有限公司 一种盐酸纳洛酮成盐的制备工艺
ES2622342T3 (es) * 2012-02-08 2017-07-06 Mallinckrodt Llc Proceso en un solo recipiente para producir 6-hidroxilo nal-opiáceos
EP2970320B1 (fr) 2013-03-15 2020-10-28 Johnson Matthey Public Limited Company Solvate méthanolique de sulfate de morphine, son processus de fabrication et ses compositions et procédés associés destinés au traitement de la douleur
CN103408553B (zh) * 2013-08-20 2016-02-03 宜昌人福药业有限责任公司 一种氢吗啡酮酸式盐的精制工艺
CN104230945B (zh) * 2014-08-23 2016-05-18 成都天台山制药有限公司 盐酸纳洛酮的合成方法
US10807995B2 (en) 2018-07-13 2020-10-20 Alkermes Pharma Ireland Limited Thienothiophene compounds for long-acting injectable compositions and related methods
WO2020012248A1 (fr) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Nouveaux composés de naphtylényle pour compositions injectables à action prolongée et procédés associés
WO2020094634A1 (fr) 2018-11-05 2020-05-14 Alkermes Pharma Ireland Limited Promédicaments de thiophène de naltroxène pour compositions injectables à action prolongée et procédés associés
CN110724155A (zh) * 2019-11-11 2020-01-24 北京华素制药股份有限公司 一种羟考酮羟醛二聚体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0421149D0 (en) * 2004-09-23 2004-10-27 Johnson Matthey Plc Preparation of oxycodone
WO2006084389A1 (fr) * 2005-02-11 2006-08-17 Cilag Ltd. Procede pour epurer des composes de noroxymorphone
CA2598774C (fr) * 2005-03-04 2010-12-21 Euro-Celtique S.A. Procede de reduction de cetones insaturees alpha et beta dans des compositions d'opioides
MX2008006710A (es) * 2005-11-22 2008-12-16 Controlled Chemicals Inc Procedimientos para reducir niveles de aceptor de michael contaminantes en oxicodona y otras composiciones.
AU2007224221B2 (en) * 2006-03-02 2013-02-14 SpecGx LLC Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
AU2007329451B2 (en) * 2006-12-04 2012-08-30 Noramco, Llc Process for reducing impurities in oxycodone base
JP2010511726A (ja) * 2006-12-04 2010-04-15 ノランコ・インコーポレーテツド １４−ヒドロキシコデイノンの濃度が低いオキシコドンの製造方法
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics

Also Published As

Publication number Publication date
UY31460A1 (es) 2009-07-17
BRPI0820300A2 (pt) 2015-05-19
TW200936592A (en) 2009-09-01
CL2008003333A1 (es) 2010-03-05
WO2009092912A1 (fr) 2009-07-30
CA2705251A1 (fr) 2009-07-30
NZ585218A (en) 2012-08-31
EP2231673A1 (fr) 2010-09-29
KR20100083815A (ko) 2010-07-22
SG186591A1 (en) 2013-01-30
EA017287B1 (ru) 2012-11-30
AU2008348675A1 (en) 2009-07-30
AR069225A1 (es) 2010-01-06
JP2011503040A (ja) 2011-01-27
FR2923484A1 (fr) 2009-05-15
EA201070589A1 (ru) 2010-10-29
US20100256176A1 (en) 2010-10-07
ZA201003241B (en) 2011-08-31
US8455509B2 (en) 2013-06-04
FR2923484B1 (fr) 2012-11-09
CN101868462A (zh) 2010-10-20
MX2010005124A (es) 2010-05-27
IL205601A0 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
MA31982B1 (fr) Procede de preparation de composes morphiniques
WO2004106279A3 (fr) Forme cristalline d'agoniste de recepteur $g(b)2-adrenergique
MA29160B1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
MA35404B1 (fr) Composés pour le traitement de la toxicomanie
WO2005092890A3 (fr) Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, et leur preparation et leurs utilisations
SG165417A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
WO2005030678A3 (fr) Agonistes ethylamino aminosubstitues du recepteur ?eta2-adrenergique
MA31926B1 (fr) Procédé pour la préparation de 1-(2h)-isoquinoléinones 6-substituées
UA90171C2 (ru) Фунгицидная композиция и способ ее получения
US4916151A (en) Method of treating parkinson's syndrome
FR2861084B1 (fr) Procede d'elimination de composes benzothiopheniques contenus dans un melange d'hydrocarbures
TW200833371A (en) Process for solid formulations
AU594722B2 (en) Nonaromatic fluoroallylamine MAO inhibitors
WO2004056769B1 (fr) Synthèse d'amines et intermédiaires pour cette synthèse
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
WO2006004976A3 (fr) Fabrication d'hydrochlorure d'atomoxetine
EP2124064A4 (fr) Procédé de préparation d'un mélange de sérum ordinaire en vue de déterminer l'activité d'un allergène et application du mélange de sérum
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
WO2004080959A3 (fr) Procede de preparation de dexmethylphenidate hydrochlorure
WO2006112742A3 (fr) Procede de preparation de derives de 13,14-dihydro-pgf2
WO2006031782A3 (fr) Ligands de recepteurs d'opiaces et leurs methodes de preparation
MXPA04000310A (es) Procedimiento para la preparacion de 2,4-didesoxihexosas y 2,4,6-tridesoxihexosas.
Brown et al. Phenoxypropylamines: a new series of squalene synthase inhibitors
WO2006097768A3 (fr) Traitement des troubles intestinaux
TW200700426A (en) Process for synthesis of diorganosilanes by disproportionation of hydridosiloxanes